X0306 4 2021-04-20 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001855980 Secora Michael C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 0 1 0 0 Chief Financial Officer Common Stock 2021-04-20 4 C 0 149077 A 528762 D Common Stock 2021-04-20 4 J 0 528762 D 0 D Class A Common Stock 2021-04-20 4 J 0 528762 A 528762 D Series D Preferred Stock 2021-04-20 4 C 0 149077 0.00 D Common Stock 149077 0 D Stock Option (Right to Buy) 2.22 2021-04-20 4 C 0 820313 0.00 D 2030-03-30 Common Stock 820313 0 D Stock Option (Right to Buy) 2.22 2021-04-20 4 C 0 1500000 0.00 D 2030-03-30 Common Stock 1500000 0 D Stock Option (Right to Buy) 2.22 2021-04-20 4 C 0 820313 0.00 A 2030-03-30 Class A Common Stock 820313 820313 D Stock Option (Right to Buy) 2.22 2021-04-20 4 C 0 1500000 0.00 A 2030-03-30 Class A Common Stock 1500000 1500000 D Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO. Each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the "Issuer") initial public offering of Class A Common Stock (the "IPO"). Each shares of Series C Preferred Stock automatically converted into Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Common Stock had no expiration date. One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. The shares subject to the award shall vest incrementally upon satisfaction of certain liquidity events. /s/ Jonathan Golightly, attorney-in-fact 2021-04-22